Farallon Capital Management (Andrew Spokes) latest 13F portfolio: 171 holdings worth $17.5B as of Q1 2026.
Backtested since 2020: mirroring Farallon Capital Management's reported 13F equity holdings each quarter would have returned +132.3% versus +176.2%for the S&P 500 (+14.6% annualized). See the Performance tab for the full equity curve.
Investor: Andrew Spokes
Number of Assets: 171
Reporting Period: Q1 - 2026
Holdings at Report: $17,464,143,931
Return $ Since Report: +$4,584,139,102
Return % Since Report: +26.25%
Company | Position | Activity | Shares | Port. % | Rep. Price | Curr. Price | Rep. Value | Curr. Value | Return Value | Return % |
|---|---|---|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals Inc. (APLS) | Equity | +100% | 6,000 | 0.00% | $40.23 | $41.03 | $241,380 | $246,180 | +$4,800 | +1.99% |
| Amicus Therapeutics Inc. (FOLD) | Equity | 0% | 16,000 | 0.00% | $14.46 | $14.49 | $231,360 | $231,840 | +$480 | +0.21% |
| Aleanna Inc. | Warrant | 0% | 990,000 | N/A | $0.81 | N/A | $801,900 | N/A | N/A | N/A |
| Centessa Pharmaceuticals PLC (CNTA) | Equity | -10.56% | 4,809,000 | 1.09% | $39.72 | $40.50 | $191,013,480 | $194,764,500 | +$3,751,020 | +1.96% |
| Blue Gold LTD | Warrant | 0% | 300,000 | N/A | $0.20 | N/A | $60,000 | N/A | N/A | N/A |
| Joyy Inc. (YY) | Equity | 0% | 578,200 | 0.19% | $58.39 | $67.25 | $33,761,098 | $38,883,950 | +$5,122,852 | +15.17% |
| Inter & CO INC | Equity | +100% | 614,500 | 0.03% | $7.96 | N/A | $4,891,420 | N/A | N/A | N/A |
| NVNI Group Limited | Warrant | 0% | 375,000 | N/A | $0.05 | N/A | $17,813 | N/A | N/A | N/A |
| Revolution Medicines Inc. (RVMDW) | Warrant | 0% | 120,085 | N/A | $1.74 | N/A | $208,948 | N/A | N/A | N/A |
| Opus Genetics INC (OCUP) | Equity | +100% | 1,000,000 | 0.03% | $4.55 | N/A | $4,550,000 | N/A | N/A | N/A |
| Solid Power Inc. (SLDPW) | Warrant | 0% | 405,316 | N/A | $0.22 | N/A | $88,359 | N/A | N/A | N/A |
| Strategy INC | Bond | +100% | 39,500,000 | N/A | $0.83 | N/A | $32,877,339 | N/A | N/A | N/A |
| Terns Pharmaceuticals Inc. (TERN) | Equity | -98.91% | 7,000 | 0.00% | $52.72 | $52.95 | $369,040 | $370,650 | +$1,610 | +0.44% |
| Vnet Group INC | Bond | +100% | 45,000,000 | N/A | $0.99 | N/A | $44,515,553 | N/A | N/A | N/A |
| Nuvalent Inc. (NUVL) | Equity | 0% | 3,000 | 0.00% | $102.45 | $123.96 | $307,350 | $371,880 | +$64,530 | +21.00% |
| Perceptive Capital Solutions corp (PCSC) | Equity | 0% | 2,250,000 | 0.14% | $10.97 | $11.95 | $24,682,500 | $26,887,500 | +$2,205,000 | +8.93% |
| Invesco S&P 500 Equal Weight Health Care ETF (RSPH) | Equity | +100% | 3,600,000 | 3.96% | $191.92 | $35.00 | $690,912,000 | $126,000,000 | -$564,912,000 | -81.76% |
| SPDR S&P 500 ETF Trust (SPY) | Equity | +100% | 2,300,000 | 8.56% | $650.34 | $768.29 | $1,495,782,000 | $1,767,067,000 | +$271,285,000 | +18.14% |
| CG Oncology Inc. (CGON) | Equity | +10825.00% | 874,000 | 0.34% | $67.68 | $72.14 | $59,152,320 | $63,050,360 | +$3,898,040 | +6.59% |
| Amkor Technology Inc. (AMKR) | Equity | -77.59% | 104,000 | 0.03% | $45.03 | $55.92 | $4,683,120 | $5,815,680 | +$1,132,560 | +24.18% |
| Ardelyx Inc. (ARDX) | Equity | 0% | 23,000 | 0.00% | $5.99 | $4.92 | $137,770 | $113,045 | -$24,725 | -17.95% |
| Avalo Therapeutics Inc. (AVTX) | Equity | +100% | 916,000 | 0.08% | $14.93 | $18.03 | $13,675,880 | $16,510,900 | +$2,835,020 | +20.73% |
| Axsome Therapeutics Inc. (AXSM) | Equity | 0% | 4,000 | 0.00% | $169.02 | $212.12 | $676,080 | $848,480 | +$172,400 | +25.50% |
| AAR Corp. (AIR) | Equity | +100% | 46,000 | 0.03% | $109.46 | $148.40 | $5,035,160 | $6,826,170 | +$1,791,010 | +35.57% |
| Abivax Société Anonyme (ABVX) | Equity | -99.48% | 2,000 | 0.00% | $111.35 | $124.91 | $222,700 | $249,820 | +$27,120 | +12.18% |
| Acadia Healthcare Company Inc. (ACHC) | Equity | +100% | 1,736,800 | 0.23% | $23.39 | $30.67 | $40,623,752 | $53,267,656 | +$12,643,904 | +31.12% |
| Alphabet Inc. (GOOG) | Equity | +26.58% | 996,231 | 1.64% | $286.86 | $372.90 | $285,778,825 | $371,489,559 | +$85,710,734 | +29.99% |
| Aramark (ARMK) | Equity | -34.43% | 6,135,431 | 1.42% | $40.54 | $56.45 | $248,730,373 | $346,345,080 | +$97,614,707 | +39.25% |
| Arcutis Biotherapeutics Inc. (ARQT) | Equity | 0% | 26,000 | 0.00% | $23.56 | $26.08 | $612,560 | $678,080 | +$65,520 | +10.70% |
| Astrazeneca PLC (AZN) | Equity | +100% | 226,499 | 0.26% | $197.22 | $157.13 | $44,670,133 | $35,589,788 | -$9,080,345 | -20.33% |
| Baidu Inc. (BIDU) | Equity | +40.75% | 443,785 | 0.28% | $111.42 | $112.48 | $49,446,525 | $49,916,937 | +$470,412 | +0.95% |
| Beam Therapeutics Inc. (BEAM) | Equity | +0.71% | 10,134,696 | 1.38% | $23.83 | $27.76 | $241,509,806 | $281,288,487 | +$39,778,681 | +16.47% |
| Belite Bio inc (BLTE) | Equity | +100% | 1,300 | 0.00% | $159.44 | $155.83 | $207,272 | $202,579 | -$4,693 | -2.26% |
| Cummins Inc. (CMI) | Equity | +100% | 9,000 | 0.03% | $538.02 | $621.20 | $4,842,180 | $5,590,800 | +$748,620 | +15.46% |
| Dianthus Therapeutics Inc. (DNTH) | Equity | +100% | 836,000 | 0.40% | $83.92 | $110.00 | $70,157,120 | $91,960,000 | +$21,802,880 | +31.08% |
| The Walt Disney Company (DIS) | Equity | -41.79% | 2,401,591 | 1.33% | $96.38 | $98.33 | $231,465,341 | $236,148,443 | +$4,683,102 | +2.02% |
| Alumis Inc. (ALMS) | Equity | +100% | 11,000 | 0.00% | $22.03 | $26.92 | $242,330 | $296,065 | +$53,735 | +22.17% |
| Alvotech (ALVO) | Equity | 0% | 199,675 | 0.00% | $3.43 | $3.81 | $684,885 | $760,762 | +$75,877 | +11.08% |
| Amazon.com Inc. (AMZN) | Equity | -6.26% | 4,218,394 | 5.03% | $208.27 | $277.31 | $878,564,918 | $1,169,802,840 | +$291,237,922 | +33.15% |
| Aon PLC (AON) | Equity | -5.73% | 2,512,638 | 4.64% | $322.78 | $353.51 | $811,029,294 | $888,242,659 | +$77,213,365 | +9.52% |
| Arrowhead Pharmaceuticals Inc. (ARWR) | Equity | 0% | 15,800 | 0.01% | $62.70 | $88.06 | $990,660 | $1,391,269 | +$400,609 | +40.44% |
| Assembly Biosciences Inc. (ASMB) | Equity | 0% | 1,227,590 | 0.20% | $27.75 | $25.75 | $34,065,623 | $31,610,443 | -$2,455,181 | -7.21% |
| Atrium Therapeutics INC (RNA) | Equity | +100% | 349,360 | 0.03% | $13.37 | $11.58 | $4,670,943 | $4,045,589 | -$625,354 | -13.39% |
| Bitwise 10 Crypto Index ETF (BITW) | Equity | -82.19% | 603,000 | 0.15% | $44.61 | $41.06 | $26,898,021 | $24,759,783 | -$2,138,238 | -7.95% |
| C4 Therapeutics Inc. (CCCC) | Equity | 0% | 28,000 | 0.00% | $2.63 | $3.52 | $73,640 | $98,560 | +$24,920 | +33.84% |
| Canopy Growth Corp. (CGC) | Equity | 0% | 30,000 | 0.00% | $0.95 | $0.93 | $28,476 | $27,930 | -$546 | -1.92% |
| Capricor Therapeutics Inc. (CAPR) | Equity | 0% | 41,000 | 0.01% | $30.40 | $4.35 | $1,246,400 | $178,145 | -$1,068,255 | -85.71% |
| Cardinal Health Inc. (CAH) | Equity | -36.11% | 368,000 | 0.45% | $211.31 | $235.49 | $77,762,080 | $86,660,320 | +$8,898,240 | +11.44% |
| Dyne Therapeutics Inc. (DYN) | Equity | 0% | 10,000 | 0.00% | $18.13 | $25.76 | $181,300 | $257,600 | +$76,300 | +42.08% |
| Enanta Pharmaceuticals Inc. (ENTA) | Equity | +3.59% | 2,871,862 | 0.21% | $12.63 | $13.38 | $36,271,617 | $38,411,154 | +$2,139,537 | +5.90% |
| Encompass Health Corp. (EHC) | Equity | -98.72% | 3,000 | 0.00% | $96.73 | $110.33 | $290,190 | $330,990 | +$40,800 | +14.06% |
| Entegris Inc. (ENTG) | Equity | +100% | 45,500 | 0.03% | $117.24 | $142.09 | $5,334,420 | $6,464,868 | +$1,130,448 | +21.19% |
| Erasca Inc. (ERAS) | Equity | +100% | 18,000 | 0.00% | $16.18 | $18.61 | $291,240 | $334,980 | +$43,740 | +15.02% |
| Flex Ltd. (FLEX) | Equity | +100% | 78,000 | 0.03% | $65.46 | $127.36 | $5,105,880 | $9,933,690 | +$4,827,810 | +94.55% |
| Adaptive Biotechnologies Corp. (ADPT) | Equity | 0% | 11,000 | 0.00% | $13.88 | $23.71 | $152,680 | $260,810 | +$108,130 | +70.82% |
| Affirm Holdings Inc. (AFRM) | Equity | +100% | 108,000 | 0.03% | $45.82 | $79.25 | $4,948,560 | $8,559,000 | +$3,610,440 | +72.96% |
| Agios Pharmaceuticals Inc. (AGIO) | Equity | +10.17% | 5,684,000 | 1.10% | $33.83 | $30.97 | $192,289,720 | $176,033,480 | -$16,256,240 | -8.45% |
| Aleanna Inc. (ANNA) | Equity | 0% | 78,400 | 0.00% | $8.29 | $2.56 | $649,936 | $200,312 | -$449,624 | -69.18% |
| Alkermes PLC (ALKS) | Equity | 0% | 20,800 | 0.00% | $35.36 | $49.26 | $735,488 | $1,024,504 | +$289,016 | +39.30% |
| Altimmune Inc. (ALT) | Equity | 0% | 27,600 | 0.00% | $3.08 | $3.00 | $85,008 | $82,662 | -$2,346 | -2.76% |
| Citigroup Inc. (C) | Equity | +100% | 47,000 | 0.03% | $113.41 | $137.39 | $5,330,270 | $6,457,330 | +$1,127,060 | +21.14% |
| Cogent Biosciences Inc. (COGT) | Equity | 0% | 17,000 | 0.00% | $38.49 | $42.62 | $654,330 | $724,540 | +$70,210 | +10.73% |
| Crinetics Pharmaceuticals Inc. (CRNX) | Equity | +20.27% | 8,338,098 | 1.73% | $36.32 | $83.96 | $302,839,719 | $700,066,708 | +$397,226,989 | +131.17% |
| Beigene Ltd (ONC) | Equity | 0% | 1,100 | 0.00% | $296.97 | $317.66 | $326,667 | $349,426 | +$22,759 | +6.97% |
| Beta Bionics Inc. (BBNX) | Equity | -16.37% | 3,607,920 | 0.21% | $10.02 | $13.84 | $36,151,358 | $49,933,613 | +$13,782,255 | +38.12% |
| Beyond Meat Inc. (BYND) | Equity | 0% | 19,000 | 0.00% | $0.70 | $0.64 | $13,330 | $12,160 | -$1,170 | -8.78% |
| Biocryst Pharmaceuticals Inc. (BCRX) | Equity | 0% | 24,000 | 0.00% | $9.52 | $8.99 | $228,480 | $215,640 | -$12,840 | -5.62% |
| Boston Scientific Corp. (BSX) | Equity | +0.42% | 7,470,684 | 2.68% | $62.75 | $48.63 | $468,785,421 | $363,262,010 | -$105,523,412 | -22.51% |
| Bridgebio Pharma Inc. (BBIO) | Equity | +4.08% | 9,365,463 | 3.98% | $74.26 | $81.36 | $695,479,282 | $761,927,242 | +$66,447,960 | +9.55% |
| Brightspring Health Services Inc. (BTSG) | Equity | +7250.00% | 1,617,000 | 0.39% | $42.61 | $62.10 | $68,900,370 | $100,415,700 | +$31,515,330 | +45.74% |
| Broadcom Inc. (AVGO) | Equity | +99.41% | 1,779,500 | 3.15% | $309.51 | $415.46 | $550,773,045 | $739,307,511 | +$188,534,466 | +34.23% |
| Cencora Inc. (COR) | Equity | 0% | 1,000 | 0.00% | $314.14 | $305.68 | $314,140 | $305,680 | -$8,460 | -2.69% |
| Ceco Environmental Corp. (CECO) | Equity | +100% | 234,000 | 0.08% | $59.58 | $70.82 | $13,941,720 | $16,571,880 | +$2,630,160 | +18.87% |
| Celcuity Inc. (CELC) | Equity | 0% | 4,000 | 0.00% | $114.14 | $91.49 | $456,560 | $365,960 | -$90,600 | -19.84% |
| Evolent Health Inc. (EVH) | Equity | 0% | 14,000 | 0.00% | $2.28 | $3.06 | $31,920 | $42,770 | +$10,850 | +33.99% |
| Exelixis Inc. (EXEL) | Equity | -16.54% | 13,111,010 | 3.22% | $42.89 | $55.85 | $562,331,219 | $732,249,909 | +$169,918,689 | +30.22% |
| Fiserv Inc. (FISV) | Equity | +100% | 86,000 | 0.03% | $55.80 | $54.45 | $4,798,800 | $4,682,700 | -$116,100 | -2.42% |
| GE Healthcare Technologies Inc. (GEHC) | Equity | 0% | 3,000 | 0.00% | $71.18 | $69.60 | $213,540 | $208,800 | -$4,740 | -2.22% |
| Geron Corp. (GERN) | Equity | 0% | 43,000 | 0.00% | $1.49 | $1.36 | $64,070 | $58,480 | -$5,590 | -8.72% |
| Glaukos Corp. (GKOS) | Equity | 0% | 2,600 | 0.00% | $107.66 | $170.15 | $279,916 | $442,390 | +$162,474 | +58.04% |
| Grail Inc. (GRAL) | Equity | +38.89% | 3,253,684 | 0.96% | $51.68 | $70.95 | $168,150,389 | $230,848,880 | +$62,698,491 | +37.29% |
| Grifols S.A. (GRFS) | Equity | 0% | 28,000 | 0.00% | $8.02 | $8.03 | $224,560 | $224,700 | +$140 | +0.06% |
| Guardant Health Inc. (GH) | Equity | -92.66% | 8,000 | 0.00% | $92.37 | $160.08 | $738,960 | $1,280,624 | +$541,664 | +73.30% |
| Hims & Hers Health Inc. (HIMS) | Equity | -99.70% | 10,000 | 0.00% | $20.76 | $31.63 | $207,600 | $316,250 | +$108,650 | +52.34% |
| Hyatt Hotels Corp. (H) | Equity | +100% | 36,000 | 0.03% | $143.79 | $174.61 | $5,176,440 | $6,285,960 | +$1,109,520 | +21.43% |
| Immunovant Inc. (IMVT) | Equity | +12783.33% | 1,546,000 | 0.22% | $24.84 | $39.33 | $38,402,640 | $60,804,180 | +$22,401,540 | +58.33% |
| Ironwood Pharmaceuticals Inc. (IRWD) | Equity | 0% | 13,000 | 0.00% | $3.51 | $4.43 | $45,630 | $57,590 | +$11,960 | +26.21% |
| KKR & Co. Inc. (KKR) | Equity | +131.54% | 4,671,800 | 2.47% | $92.50 | $107.71 | $432,141,500 | $503,176,219 | +$71,034,719 | +16.44% |
| Krystal Biotech Inc. (KRYS) | Equity | -50.00% | 1,000 | 0.00% | $258.32 | $323.00 | $258,320 | $323,000 | +$64,680 | +25.04% |
| Madrigal Pharmaceuticals Inc. (MDGL) | Equity | 0% | 3,319 | 0.01% | $523.47 | $502.33 | $1,737,397 | $1,667,217 | -$70,180 | -4.04% |
| Formfactor Inc. (FORM) | Equity | +100% | 56,500 | 0.03% | $96.99 | $119.55 | $5,479,935 | $6,754,575 | +$1,274,640 | +23.26% |
| Garrett Motion Inc. (GTX) | Equity | +100% | 275,000 | 0.03% | $18.17 | $30.98 | $4,996,750 | $8,518,125 | +$3,521,375 | +70.47% |
| GDS Holdings Limited (GDS) | Equity | +100% | 292,000 | 0.07% | $40.29 | $33.07 | $11,764,680 | $9,654,980 | -$2,109,700 | -17.93% |
| Healthcare Realty Trust Inc. (HR) | Equity | 0% | 12,000 | 0.00% | $16.99 | $20.32 | $203,880 | $243,780 | +$39,900 | +19.57% |
| Healthequity Inc. (HQY) | Equity | -44.00% | 2,800 | 0.00% | $83.57 | $104.32 | $233,996 | $292,096 | +$58,100 | +24.83% |
| Johnson & Johnson (JNJ) | Equity | +100% | 148,000 | 0.21% | $244.44 | $252.03 | $36,177,120 | $37,300,144 | +$1,123,024 | +3.10% |
| Lantheus Holdings Inc. (LNTH) | Equity | +2.87% | 5,583,479 | 2.43% | $75.85 | $101.08 | $423,506,882 | $564,350,140 | +$140,843,258 | +33.26% |
| Mastercard Inc. (MA) | Equity | +151.97% | 435,071 | 1.24% | $499.66 | $571.10 | $217,387,576 | $248,469,048 | +$31,081,472 | +14.30% |
| Mckesson Corp. (MCK) | Equity | -21.61% | 234,300 | 1.16% | $865.36 | $832.45 | $202,753,848 | $195,041,864 | -$7,711,985 | -3.80% |
| Merck & Co. Inc. (MRK) | Equity | +100% | 361,000 | 0.25% | $120.29 | $127.66 | $43,424,690 | $46,085,260 | +$2,660,570 | +6.13% |
| Merit Medical Systems Inc. (MMSI) | Equity | 0% | 3,000 | 0.00% | $68.93 | $84.79 | $206,790 | $254,370 | +$47,580 | +23.01% |
| Mirum Pharmaceuticals Inc. (MIRM) | Equity | 0% | 3,000 | 0.00% | $92.38 | $104.05 | $277,140 | $312,135 | +$34,995 | +12.63% |
| Natera Inc. (NTRA) | Equity | -18.06% | 3,207,366 | 3.67% | $199.99 | $271.85 | $641,441,126 | $871,922,447 | +$230,481,321 | +35.93% |
| Nektar Therapeutics (NKTR) | Equity | +100% | 4,000 | 0.00% | $71.95 | $72.27 | $287,800 | $289,060 | +$1,260 | +0.44% |
| Netease Inc. (NTES) | Equity | +100% | 291,219 | 0.19% | $111.94 | $130.01 | $32,599,055 | $37,859,926 | +$5,260,871 | +16.14% |
| Piper Sandler Companies (PIPR) | Equity | +100% | 66,000 | 0.03% | $76.55 | $76.75 | $5,052,300 | $5,065,500 | +$13,200 | +0.26% |
| Rani Therapeutics Holdings Inc. (RANI) | Equity | 0% | 78,000 | 0.00% | $0.73 | $0.85 | $57,314 | $66,300 | +$8,986 | +15.68% |
| Royalty Pharma PLC (RPRX) | Equity | +100% | 493,000 | 0.14% | $47.97 | $57.79 | $23,649,210 | $28,488,005 | +$4,838,795 | +20.46% |
| Genedx Holdings Corp. (WGS) | Equity | -92.86% | 5,000 | 0.00% | $64.22 | $66.81 | $321,100 | $334,050 | +$12,950 | +4.03% |
| Globalfoundries Inc. (GFS) | Equity | +100% | 105,000 | 0.03% | $44.48 | $52.51 | $4,670,400 | $5,513,025 | +$842,625 | +18.04% |
| Globus Medical Inc. (GMED) | Equity | 0% | 4,000 | 0.00% | $86.16 | $80.99 | $344,640 | $323,960 | -$20,680 | -6.00% |
| Microsoft Corp. (MSFT) | Equity | +5.90% | 2,344,779 | 4.97% | $370.17 | $496.99 | $867,966,842 | $1,165,319,991 | +$297,353,149 | +34.26% |
| Minerva Neurosciences Inc. (NERV) | Equity | 0% | 2,365,000 | 0.08% | $6.03 | $4.07 | $14,249,125 | $9,625,550 | -$4,623,575 | -32.45% |
| Molina Healthcare Inc. (MOH) | Equity | +100% | 35,000 | 0.03% | $133.30 | $191.76 | $4,665,500 | $6,711,600 | +$2,046,100 | +43.86% |
| Nuvation Bio Inc. (NUVB) | Equity | 0% | 29,000 | 0.00% | $4.29 | $6.45 | $124,410 | $186,905 | +$62,495 | +50.23% |
| Precigen Inc. (PGEN) | Equity | 0% | 50,000 | 0.00% | $3.87 | $6.64 | $193,500 | $331,750 | +$138,250 | +71.45% |
| S&P Global Inc. (SPGI) | Equity | +100% | 12,000 | 0.03% | $425.34 | $417.10 | $5,104,080 | $5,005,200 | -$98,880 | -1.94% |
| Sabra Health Care Reit Inc. (SBRA) | Equity | 0% | 14,000 | 0.00% | $19.23 | $20.04 | $269,220 | $280,490 | +$11,270 | +4.19% |
| Ionis Pharmaceuticals Inc. (IONS) | Equity | 0% | 4,800 | 0.00% | $75.09 | $54.73 | $360,432 | $262,680 | -$97,752 | -27.12% |
| Iovance Biotherapeutics Inc. (IOVA) | Equity | 0% | 26,000 | 0.00% | $3.51 | $4.39 | $91,260 | $114,010 | +$22,750 | +24.93% |
| Mastec Inc. (MTZ) | Equity | +100% | 17,000 | 0.03% | $321.74 | $271.04 | $5,469,580 | $4,607,680 | -$861,900 | -15.76% |
| Neogenomics Inc. (NEO) | Equity | 0% | 19,000 | 0.00% | $7.42 | $16.22 | $140,980 | $308,180 | +$167,200 | +118.60% |
| Novavax Inc. (NVAX) | Equity | -88.72% | 22,000 | 0.00% | $8.14 | $7.61 | $179,080 | $167,420 | -$11,660 | -6.51% |
| Novo Nordisk As (NVO) | Equity | +100% | 782,000 | 0.16% | $36.75 | $47.35 | $28,738,500 | $37,023,790 | +$8,285,290 | +28.83% |
| Revolution Medicines Inc. (RVMD) | Equity | -6.71% | 13,604,796 | 7.58% | $97.25 | $189.19 | $1,323,066,411 | $2,573,891,355 | +$1,250,824,944 | +94.54% |
| Rio Tinto Group (RIO) | Equity | +100% | 53,800 | 0.03% | $93.29 | $98.64 | $5,019,002 | $5,306,832 | +$287,830 | +5.73% |
| Roivant Sciences Ltd. (ROIV) | Equity | +26048.65% | 9,675,000 | 1.53% | $27.70 | $34.36 | $267,997,500 | $332,384,625 | +$64,387,125 | +24.03% |
| Liquidia Corp. (LQDA) | Equity | 0% | 8,656,038 | 1.87% | $37.74 | $87.97 | $326,678,874 | $761,471,663 | +$434,792,789 | +133.09% |
| Littelfuse Inc. (LFUS) | Equity | +100% | 15,000 | 0.03% | $339.35 | $461.49 | $5,090,250 | $6,922,350 | +$1,832,100 | +35.99% |
| Livanova PLC (LIVN) | Equity | 0% | 6,000 | 0.00% | $63.56 | $82.92 | $381,360 | $497,490 | +$116,130 | +30.45% |
| Maze Therapeutics Inc. (MAZE) | Equity | +100% | 373,000 | 0.06% | $29.85 | $27.61 | $11,134,050 | $10,298,530 | -$835,520 | -7.50% |
| Ocular Therapeutix Inc. (OCUL) | Equity | 0% | 18,000 | 0.00% | $8.47 | $8.57 | $152,460 | $154,170 | +$1,710 | +1.12% |
| Oscar Health Inc. (OSCR) | Equity | -95.83% | 11,000 | 0.00% | $11.47 | $30.53 | $126,170 | $335,830 | +$209,660 | +166.17% |
| Pacific Biosciences Of California Inc. (PACB) | Equity | 0% | 135,000 | 0.00% | $1.32 | $1.46 | $178,200 | $196,425 | +$18,225 | +10.23% |
| Rollins Inc. (ROL) | Equity | +100% | 93,000 | 0.03% | $53.41 | $37.71 | $4,967,130 | $3,507,030 | -$1,460,100 | -29.40% |
| Scholar Rock Holding Corp. (SRRK) | Equity | 0% | 7,000 | 0.00% | $49.16 | $47.26 | $344,120 | $330,820 | -$13,300 | -3.86% |
| Schrödinger Inc. (SDGR) | Equity | -76.06% | 17,000 | 0.00% | $11.36 | $15.57 | $193,120 | $264,690 | +$71,570 | +37.06% |
| The Charles Schwab Corp. (SCHW) | Equity | +18.45% | 3,955,657 | 2.13% | $93.98 | $106.18 | $371,752,645 | $420,011,660 | +$48,259,015 | +12.98% |
| Sellas Life Sciences Group Inc. (SLS) | Equity | +100% | 40,000 | 0.00% | $4.23 | $11.45 | $169,200 | $458,000 | +$288,800 | +170.69% |
| Servicenow Inc. (NOW) | Equity | +100% | 41,000 | 0.02% | $104.55 | $115.68 | $4,286,550 | $4,742,675 | +$456,125 | +10.64% |
| Stoke Therapeutics Inc. (STOK) | Equity | 0% | 9,000 | 0.00% | $32.56 | $30.22 | $293,040 | $271,980 | -$21,060 | -7.19% |
| Summit Midstream Corp. (SMC) | Equity | 0% | 58,214 | 0.01% | $30.24 | $30.41 | $1,760,391 | $1,770,288 | +$9,897 | +0.56% |
| Supernus Pharmaceuticals Inc. (SUPN) | Equity | +100% | 4,000 | 0.00% | $51.69 | $44.21 | $206,760 | $176,840 | -$29,920 | -14.47% |
| Tango Therapeutics Inc. (TNGX) | Equity | -30.35% | 9,097,411 | 1.09% | $20.92 | $28.45 | $190,317,838 | $258,821,343 | +$68,503,505 | +35.99% |
| Tenable Holdings Inc. (TENB) | Equity | +100% | 265,000 | 0.03% | $16.92 | $35.94 | $4,482,475 | $9,524,100 | +$5,041,625 | +112.47% |
| Omeros Corporation (OMER) | Equity | 0% | 23,000 | 0.00% | $10.56 | $12.65 | $242,880 | $290,835 | +$47,955 | +19.74% |
| Prime Medicine Inc. (PRME) | Equity | 0% | 1,240,843 | 0.02% | $3.48 | $2.95 | $4,318,134 | $3,654,283 | -$663,851 | -15.37% |
| Progyny Inc. (PGNY) | Equity | 0% | 18,000 | 0.00% | $16.98 | $31.42 | $305,640 | $565,560 | +$259,920 | +85.04% |
| Protagonist Therapeutics Inc. (PTGX) | Equity | +3.33% | 6,348,906 | 3.83% | $105.40 | $133.89 | $669,174,692 | $850,055,024 | +$180,880,332 | +27.03% |
| Tenet Healthcare Corp. (THC) | Equity | +21.50% | 452,153 | 0.49% | $188.71 | $249.22 | $85,325,793 | $112,685,571 | +$27,359,778 | +32.07% |
| Teva Pharmaceutical Industries Limited (TEVA) | Equity | +785.00% | 354,000 | 0.06% | $30.12 | $34.19 | $10,662,480 | $12,101,490 | +$1,439,010 | +13.50% |
| Thermo Fisher Scientific Inc. (TMO) | Equity | +38.67% | 881,485 | 2.48% | $491.53 | $564.40 | $433,276,322 | $497,505,727 | +$64,229,405 | +14.82% |
| The Timken Company (TKR) | Equity | +100% | 51,000 | 0.03% | $100.57 | $131.77 | $5,129,070 | $6,720,270 | +$1,591,200 | +31.02% |
| Vertiv Holdings Co (VRT) | Equity | +100% | 19,000 | 0.03% | $250.58 | $274.94 | $4,761,020 | $5,223,860 | +$462,840 | +9.72% |
| Urogen Pharma Ltd. (URGN) | Equity | 0% | 11,000 | 0.00% | $17.98 | $39.29 | $197,780 | $432,135 | +$234,355 | +118.49% |
| Vaxcyte Inc. (PCVX) | Equity | +25120.00% | 1,261,000 | 0.42% | $58.11 | $54.64 | $73,276,710 | $68,901,040 | -$4,375,670 | -5.97% |
| Veracyte Inc. (VCYT) | Equity | 0% | 7,000 | 0.00% | $32.21 | $46.11 | $225,470 | $322,735 | +$97,265 | +43.14% |
| Syndax Pharmaceuticals Inc. (SNDX) | Equity | 0% | 10,000 | 0.00% | $23.36 | $19.53 | $233,600 | $195,300 | -$38,300 | -16.40% |
| Synopsys Inc. (SNPS) | Equity | +21.43% | 1,213,300 | 2.75% | $396.48 | $399.35 | $481,049,184 | $484,531,355 | +$3,482,171 | +0.72% |
| Travere Therapeutics Inc. (TVTX) | Equity | 0% | 12,000 | 0.00% | $29.71 | $55.00 | $356,520 | $660,000 | +$303,480 | +85.12% |
| Tvardi Therapeutics INC (TVRD) | Equity | -50.40% | 21,438 | 0.00% | $3.18 | $2.05 | $68,173 | $43,841 | -$24,332 | -35.69% |
| Twist Bioscience Corp. (TWST) | Equity | +18562.09% | 1,427,650 | 0.39% | $47.52 | $100.29 | $67,841,928 | $143,179,019 | +$75,337,091 | +111.05% |
| Tyra Biosciences Inc. (TYRA) | Equity | +73.25% | 3,580,818 | 0.79% | $38.30 | $32.68 | $137,145,329 | $117,021,132 | -$20,124,197 | -14.67% |
| Visa Inc. (V) | Equity | +20.81% | 840,710 | 1.45% | $302.24 | $368.62 | $254,096,190 | $309,902,520 | +$55,806,330 | +21.96% |
| VNet Group Inc. (VNET) | Equity | -90.08% | 623,347 | 0.03% | $8.39 | $7.20 | $5,229,881 | $4,484,982 | -$744,899 | -14.24% |
| Westinghouse Air Brake Technologies Corp. (WAB) | Equity | -35.00% | 1,609,403 | 2.30% | $249.91 | $299.32 | $402,205,904 | $481,726,506 | +$79,520,602 | +19.77% |
| Welltower Inc. (WELL) | Equity | -41.69% | 200,000 | 0.23% | $197.71 | $228.51 | $39,542,000 | $45,701,000 | +$6,159,000 | +15.58% |
| Western Alliance Bancorporation (WAL) | Equity | +100% | 73,000 | 0.03% | $70.85 | $84.79 | $5,172,050 | $6,189,305 | +$1,017,255 | +19.67% |
| Uniqure N.V. (QURE) | Equity | 0% | 14,000 | 0.00% | $16.35 | $43.77 | $228,900 | $612,780 | +$383,880 | +167.71% |
| UnitedHealth Group Inc. (UNH) | Equity | +13.93% | 1,821,706 | 2.82% | $270.59 | $408.65 | $492,935,427 | $744,440,157 | +$251,504,730 | +51.02% |
| Vir Biotechnology Inc. (VIR) | Equity | +100% | 22,000 | 0.00% | $8.96 | $9.26 | $197,120 | $203,610 | +$6,490 | +3.29% |